IRVING, Texas, May 3, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company's MI Transcriptome™...
from PR Newswire: https://prn.to/2PSsRGh
No comments:
Post a Comment